Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.55M Sell
280,082
-375,933
-57% -$6.7M ﹤0.01% 2226
2026
Q1
$12.5M Sell
656,015
-37,296
-5% -$721K 0.01% 1260
2025
Q4
$11.3M Buy
693,311
+361,564
+109% +$6.37M 0.02% 1037
2025
Q3
$6.23M Buy
331,747
+87,224
+36% +$1.56M 0.01% 1283
2025
Q2
$4.94M Buy
+244,523
New +$4.23M 0.01% 1243
2024
Q4
Sell
-76,077
Closed -$1.36M 3523
2024
Q3
$1.36M Buy
+76,077
New +$1.39M ﹤0.01% 1928
2024
Q2
Sell
-2,759,826
Closed -$70.8M 3379
2024
Q1
$70.8M Sell
2,759,826
-1,685,890
-38% -$42.3M 0.17% 157
2023
Q4
$116M Buy
4,445,716
+2,850,140
+179% +$65M 0.27% 92
2023
Q3
$36.8M Buy
1,595,576
+1,454,271
+1,029% +$36.5M 0.1% 247
2023
Q2
$3.32M Sell
141,305
-252,615
-64% -$4.29M 0.01% 1132
2023
Q1
$4.68M Buy
393,920
+164,581
+72% +$2.35M 0.01% 946
2022
Q4
$3.52M Buy
+229,339
New +$4.01M 0.01% 1033
2021
Q1
Sell
-21,413
Closed -$914K 4306
2020
Q4
$849K Buy
+21,413
New +$875K ﹤0.01% 2129

Other funds holding XP

John Overdeck's XP Position: Q2 2026 in Review

John Overdeck reduced its XP (XP) stake by 57% in Q2 2026, selling an estimated $6.7M and leaving 280,082 shares worth $4.55M. The position accounts for ﹤0.01% of the portfolio, ranked #2226.

John Overdeck first reported a position in XP in Q4 2020 and has held it in 13 quarters since. The position peaked at $116M in Q4 2023. 319 funds tracked by Wall St. Rank hold XP as of Q2 2026.

  • John Overdeck held 280,082 shares of XP worth $4.55M as of Q2 2026.
  • John Overdeck sold 375,933 XP shares in Q2 2026, an estimated $6.7M.
  • XP made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #2226 holding.
  • John Overdeck first reported a position in XP in Q4 2020 and has held it in 13 quarters since.
  • John Overdeck's XP position peaked at $116M in Q4 2023.
  • 319 funds tracked by Wall St. Rank held XP as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.